Welcome to our dedicated page for PetVivo Holdings SEC filings (Ticker: PETV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PetVivo Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PetVivo Holdings's regulatory disclosures and financial reporting.
PetVivo Holdings, Inc. converted outstanding shareholder debt into equity. Effective as of September 30, 2025, four shareholders holding fourteen promissory notes with an aggregate outstanding amount of $2,018,155, including $1,850,000 of principal and $168,155 of accrued interest, agreed to convert their notes into 3,669,806 shares of PetVivo common stock. The effective conversion prices ranged from $0.50 to $0.75 per share, and the notes were fully converted, treated as paid in full, and cancelled once the shares were issued.
The shares issued are restricted securities, relying on an exemption from registration under Section 4(a)(2) of the Securities Act. The lenders represented that they are accredited investors acquiring the shares for investment, and the stock certificates bear a legend stating that the securities are restricted and cannot be sold or transferred without registration or an applicable exemption.
PetVivo Holdings, Inc. reporting person John Lai, who serves as Chief Executive Officer and a director, reported a non‑derivative acquisition on 09/18/2025. The filing shows a grant of 84,375 shares of common stock at a price of $0.76 to a corporation owned by the reporting person as compensation for past performance, reflecting conversion of a past accrued bonus into common stock. Following the transaction, the reporting person (indirectly) beneficially owned 2,020,710 shares. The Form 4 is signed by John Lai on 09/22/2025. The filing indicates the award was issued as compensation rather than a market purchase.
Garry Lowenthal, Chief Financial Officer of PetVivo Holdings, Inc., received a grant of restricted common stock on 09/18/2025 as compensation for past performance. The grant consisted of 79,375 shares at a stated price of $0.76 and was issued to a corporation owned by Mr. Lowenthal. After the reported transaction, the reporting persons indirect beneficial ownership totaled 592,967 shares. The Form 4 indicates this was a non-derivative award recorded as an acquisition and identifies the grant as compensation rather than a market purchase.